Ability of the rhTSH stimulation test to predict relapse in patients with differentiated thyroid carcinoma, after long-term follow-up

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1281-1286

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of whole-body retention of iodine-131 (131I) after postoperative remnant ablation for differentiated thyroid carcinoma – thyroxine withdrawal versus rhTSH administration: A retrospective comparison

By      

Oncology Letters, Vol. 3, Iss. 3, 2012-01 ,pp. : 617-620

Spandidos Publications

Access to resources Recommend Favorite

Present status of the use of recombinant human TSH in thyroid cancer managementPresented at Scandinavian Society for Head and Neck Oncology, XVIII Annual Meeting, Odense, Denmark, April 2006.

By Luster Markus  

Acta Oncologica, Vol. 45, Iss. 8, 2006-12 ,pp. : 1018-1030

Informa Healthcare

Access to resources Recommend Favorite

High-dose Melphalan with Re-infusion of Unprocessed, G-CSF-primed Whole Blood is Effective and Non-toxic Therapy in Multiple Myeloma

By Ossenkoppele G.J.   Schuurhuis G.J.   Jonkhoff A.R.   van der Hem K.G.   Legdeur M.C.J.C.   Boot-Bakker A.   Westra A.H.   Drager A.M.   Huijgens P.C.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2058-2063

Elsevier

Access to resources Recommend Favorite

Effect of Non-toxic Concentrations of Acriflavine on Unscheduled DNA-synthesis and Survival of Synchronized HeLa Cells Exposed to Ultra-violet Light

By Evans Richard G.   Djordjevic Bozidar  

International Journal of Radiation Biology, Vol. 15, Iss. 3, 1969-05 ,pp. : 239-244

Informa Healthcare

Access to resources Recommend Favorite